Magsayo, Joelyn D.
HRN: 27-37-08 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/19/2026
CO-AMOXICLAV 625MG (TAB)
02/19/2026
02/26/2026
PO
625mg
BID X 7 Days
S/P NSVD With RMLE
Checking Initial Appropriateness